Get the Stockscreener App
10.09
0.10%
0.010
Drugs Made In America Acquisition Ii Corp stock is traded at $10.09, with a volume of 65,116.
It is up +0.10% in the last 24 hours and up +0.60% over the past month.
Drugs Made In America Acquisition II Corp is a blank check Company.
See More
Previous Close:
$10.08
Open:
$10.08
24h Volume:
65,116
Relative Volume:
0.64
Market Cap:
$642.10M
Revenue:
-
Net Income/Loss:
$8.58M
P/E Ratio:
75.30
EPS:
0.134
Net Cash Flow:
$-1.11M
1W Performance:
+0.00%
1M Performance:
+0.60%
6M Performance:
+2.23%
1Y Performance:
+0.00%
1-Day Range:
$10.07
$10.09
1-Week Range:
$10.07
$10.09
52-Week Range:
$9.87
$10.09
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
Name
Drugs Made In America Acquisition Ii Corp
Sector
Industry
Phone
954-870-3104
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.08 | 642.10M | 0 | 8.58M | -1.11M | 0.134 |
LION
Lionsgate Studios Corp
|
16.48 | 4.18B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
6.06 | 2.11B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
24.50 | 1.18B | 17.25M | -5.64M | -40.16M | -0.3337 |
BCSS
Bain Capital Gss Investment Corp
|
10.21 | 596.26M | 0 | 8.29M | -686.50K | 0.142 |
Drugs Made In America Acquisition Ii Corp Stock (DMII) Latest News
DMAAR Rights Trade Flat Near All-Time Low as Investors Await Merger CatalystBearish Pattern Stocks - newsline.com
DMAA Hovers Near $10.62 as SPAC Consolidates Ahead of Potential CatalystFair Value Gap - newsline.com
US Retreat from Global Leadership Stirs Uncertainty Across AsiaFinancial Health Score - newsline.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Holds Flat at $0.08 as Rights Trading Remains DormantDip Buy Trade - newsline.com
Omega Healthcare Investors (OHI) Rises 1.08% as Real Estate Sector Finds FootingBull Pennant - newsline.com
DMII Holds Steady at $10.08: SPAC Trading in a Narrow RangeTICK Divergence - newsline.com
DMIIU Holds Steady at $10.12 as SPAC Unit Trades in Tight RangeFear Greed Extreme - newsline.com
DMIIR Rights Trading Slumps 9.09% to $0.08 – Micro-Cap Struggles for DirectionReversal Setup Alerts - newsline.com
North Carolina Treasurer Shuns SpaceX Investment, Favors AI Startups OpenAI and AnthropicRevenue Guidance Update - newsline.com
SpaceX IPO May Serve as ‘Referendum’ on Elon Musk’s Leadership, Market Observers SuggestBuyback Announcement Report - newsline.com
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
Rajesh Exports Faces Potential Removal from PLI Scheme; Decision Expected ShortlyDebt Analysis Report - newsline.com
Eli Lilly and Company - Britannica
Ispire Technology Inc. (ISPR) Edges Higher as Stock Approaches Key Resistance at $1.78getLinesFromResByArray error: size == 0 - The League of Women Voters of Texas
Brand Engagement Network Inc. (BNAI) Q3 2025 Earnings: Narrowed Loss Surprises as Pre-Revenue Company Gains MomentumEarnings Growth Forecast - newsline.com
Selective Insurance Group (SIGI) Surges 3% as Stock Approaches Key Resistance LevelStock Picks - newsline.com
CCK Q1 2026 Earnings: EPS Surpasses Estimates by 6.43%Post-Earnings Reaction - newsline.com
Free float of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
QDRO Acquisition Corp.: Performance & Quotes, QADR Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
DOUG Q4 2025 Earnings: Massive EPS Miss Sends Shares LowerQuarterly Earnings - newsline.com
Drugs Made In America Acquisition Corp. Rights (DMAAR) Edge Higher Amid Low-Price SpeculationSector Leader Stocks - newsline.com
Shalibhadra Finance Targets Rs 500 Crore AUM on 22% Profit Growth in FY26Net Income Trends - The Legal Advocate
Drugs Made In America Acquisition II Corp. Right (DMIIR) Drops 10% as Rights Trade Near Support at $0.08Volatility Breakout Picks - The Legal Advocate
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Amid Extended ConsolidationVolatility Smirk - The Legal Advocate
Drugs Made In America Acquisition Corp. Rights (DMAAR) Slides 7.4% – Testing Key Support ZoneRip Sell Trade - newsline.com
NXRT Q1 2026 Earnings: Narrower-Than-Expected Loss, Stock Edges LowerBanking Earnings Report - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Moves Up 8.91% at $0.09 – Right Securities See Renewed InterestGamma Squeeze - The Legal Advocate
NXGL Q1 2026 Earnings: Larger-Than-Expected Loss Weighs on SharesEarnings Manipulation Risk - thelegaladvocate.com
Evolution Global Acquisition Corp Warrants (EVOXW) Surge 18.6% as Price Approaches Key ResistanceChaikin Flow - The Legal Advocate
Trump Media & Technology Group (DJT) Rises 3.5% as Stock Bounces From SupportBackspread Trade - thelegaladvocate.com
DMII Holds Steady at $10.07 as SPAC Shares Track Trust ValueRating Change - newsline.com
DMIIU Units Edge Lower by 0.44% as Price Holds Near $10.11 Amid Quiet TradingVWAP Breakout - The Legal Advocate
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Near Trust Value Amid Low VolatilityInstitutional Sentiment - The Legal Advocate
DMIIR Rights Hover at $0.09 as Flat Trading Persists for Drugs Made In America Acquisition II Corp.Social Sentiment - The Legal Advocate
Huadi International Group (HUDI) Faces Steep Decline, Testing Key Support at $1.0Turnaround Stocks - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. (DMII) Holds Steady Near Resistance: A Detailed AnalysisAdaptive Moving Average - The Legal Advocate
Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Support as SPAC Market Awaits CatalystLarge Cap Trends - newsline.com
Drugs Made In America Acquisition Corp. Rights (DMAAR) Edges Higher: Analyzing the $0.12 LevelLiquidity Order Flow - newsline.com
SAGU_u|SAGU_u.NB|Price:10.090|Chg%:0.04 - TradingKey
AGNCO Q1 2026 Earnings: Strong EPS Surprise of 14.5% Drives Positive Stock MovementPeak Earnings Alert - newsline.com
symbol__ Stock Quote Price and Forecast - CNN
MMCAP International Inc. SPC's Drugs Made In America Acquisition II Corp(DMII) Holding History - GuruFocus
BioLife Solutions (BLFS) Faces Headwinds: Shares Decline 3.19% to $23.95ADD Alert - newsline.com
Trump-Xi Summit: The 3 Big Takeaways from Historic Meeting in BeijingReturn On Equity - The Legal Advocate
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Harmony Gold (HMY) Slides 1.4% as Gold Prices Retreat, Approaches Key SupportAccumulation Line - newsline.com
Trump and Mark Cuban team up to take on America's drug pricing crisis - Fortune
Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension - AstraZeneca
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Drugs Made In America Acquisition Ii Corp Stock (DMII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):